UPDATE: Correction - Canaccord Genuity Maintains a 'Buy' on Incyte (INCY); Q2 and Guidance Raises Several Questions
Go back to UPDATE: Correction - Canaccord Genuity Maintains a 'Buy' on Incyte (INCY); Q2 and Guidance Raises Several Questions| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 51.18 -0.56 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.74 | 52 Week High | $118.49 | |||
| Open | $51.58 | 52 Week Low | $55.00 | |||
| Day High | $51.85 | P/E | N/A | |||
| Day Low | $50.35 | EPS | $-0.56 | |||
| Volume | 1,771,950 | |||||
